Healthcare -
Biotechnology - NASDAQ - US
$ 11.2
1.08 %
$ 454 M
Market Cap
-2.24
P/E
KROS - TOTAL EQUITY
Total Equity KROS - Keros Therapeutics, Inc.
332 M
LAST VALUE
16.88%
2 YEAR CAGR
91.92%
5 YEAR CAGR
0.00%
10 YEAR CAGR